Edwards Lifesciences Cash Flow Statement

EW $88.56 -0.5 -0.5%

19/04/21

Balanced, Large Cap, Falling Star

Market Cap £39.55bn

Enterprise Value £38.98bn

Revenue £3.14bn

Quality

Value

Momentum

StockRank™

To unlock Edwards Lifesciences's cashflow statement please upgrade your membership.

	2015	2016	2017	2018	2019	2020
Period End:	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31
Period Length:	12M	12M	12M	12M	12M	12M
Currency:	USD	USD	USD	USD	USD	USD

Net Income/Starting Line

Depreciation/Depletion
Deferred Taxes
Non-Cash Items
Unusual Items
Purchased R&D
Other Non-Cash Items
Changes in Working Capital
Accounts Receivable
Inventories
Prepaid Expenses
Accrued Expenses
Payable/Accrued
Taxes Payable
Other Assets & Liabilities, Net
Cash from Operating Activities

Capital Expenditures
Purchase of Fixed Assets
Purchase/Acquisition of Intangibles
Other Investing Cash Flow Items, Total
Acquisition of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Investment, Net
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities

Financing Cash Flow Items
Other Financing Cash Flow
Issuance (Retirement) of Stock, Net
Issuance (Retirement) of Debt, Net
Cash from Financing Activities

Foreign Exchange Effects
Net Change in Cash
Starting Cash Balance
Ending Cash Balance

Unlock Stockopedia Premium for free!

See what it can do for your stockpicking and portfolio at no expense.